Journal article
Courses for horses: Rethinking the use of proton pump inhibitors in the treatment of equine gastric ulcer syndrome
Equine veterinary education, Vol.31(8), pp.441-446
08/2019
Metrics
7 Record Views
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Abstract
Oral omeprazole has been the cornerstone of equine gastric ulcer syndrome (EGUS) treatment for nearly 20 years. However, approximately 15–30% of equine squamous gastric disease (ESGD) cases and 75% of equine glandular gastric disease (EGGD) cases fail to heal within current treatment guidelines. Recently, a number of factors that may affect the efficacy of oral omeprazole have been highlighted and the pharmacodynamics of a number of novel proton pump inhibitors (PPIs) have been described in the horse. The purpose of this article is to review the factors that affect oral omeprazole efficacy, with the goal of maximising therapeutic response, and the novel PPIs recently described.
Details
- Title
- Courses for horses: Rethinking the use of proton pump inhibitors in the treatment of equine gastric ulcer syndrome
- Creators
- B. W. Sykes - University of Queensland
- Publication Details
- Equine veterinary education, Vol.31(8), pp.441-446
- Publisher
- John Wiley & Sons, Inc.
- Number of pages
- 6
- Identifiers
- 991013160051302368
- Copyright
- © 2018 EVJ Ltd.
- Academic Unit
- Faculty of Science and Engineering
- Language
- English
- Resource Type
- Journal article